U.S. Capital Wealth Advisors, LLC Dexcom Inc Transaction History

U.S. Capital Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $312 - $368	3 Added 0.02%	14,780 $1.72 Million
Q4 2022 Feb 03, 2023	BUY	$84.98 - $122.67 $4,164 - $6,010	49 Added 0.33%	14,777 $1.67 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $750,813 - $1.47 Million	11,043 Added 299.67%	14,728 $1.1 Million
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $46,757 - $64,709	-497 Reduced 11.88%	3,685 $1.89 Million
Q4 2021 Jan 21, 2022	SELL	$129.87 - $162.82 $339,869 - $426,099	-2,617 Reduced 38.49%	4,182 $2.25 Million
Q3 2021 Nov 01, 2021	BUY	$106.71 - $143.18 $725,521 - $973,480	6,799 New	6,799 $3.3 Million

1,085

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.